XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debts - Narrative (Details)
1 Months Ended 3 Months Ended 12 Months Ended 19 Months Ended
Oct. 04, 2021
USD ($)
$ / shares
shares
Jul. 16, 2021
USD ($)
Feb. 12, 2020
shares
$ / shares
Jun. 30, 2022
USD ($)
segment
Oct. 31, 2021
USD ($)
shares
Jul. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2022
USD ($)
segment
Jun. 30, 2021
USD ($)
Mar. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
segment
Jan. 10, 2022
$ / shares
May 19, 2021
USD ($)
May 18, 2021
USD ($)
Mar. 31, 2021
USD ($)
Mar. 01, 2021
USD ($)
Mar. 31, 2020
USD ($)
Apr. 04, 2018
USD ($)
Oct. 31, 2017
USD ($)
Debt Instrument [Line Items]                                      
Principal amount of development loans outstanding       $ 12,182,000       $ 12,182,000     $ 12,182,000                
Long-term loan facility                                   $ 15,000,000  
Conversion price per share on convertible note payable (in dollars per share) | $ / shares     $ 5.12                                
Exercise price (in usd per share) | $ / shares                       $ 3.30              
Other income               445,000 $ 270,000                    
Changes in fair value of promissory note               0 1,024,000                    
Interest expense               (182,000) (204,000)                    
2022 Amended Cooperation And Development Agreement, Commitment One                                      
Debt Instrument [Line Items]                                      
Revenue recognized for collaboration development activities                     $ 2,500,000                
Twenty Twenty Two Amended Cooperation And Development Agreement, Commitment Two                                      
Debt Instrument [Line Items]                                      
Revenue recognized for collaboration development activities               $ 172,000                      
2020 Cooperation and Development Agreement                                      
Debt Instrument [Line Items]                                      
Term of cooperation and development agreement.             3 years                        
Yaskawa                                      
Debt Instrument [Line Items]                                      
Number of collaborative agreement contracts | segment       2       2     2                
Yaskawa | 2022 Amended Cooperation And Development Agreement, Commitment One                                      
Debt Instrument [Line Items]                                      
Cooperative and development activities               $ 2,500,000                      
Yaskawa | Twenty Twenty Two Amended Cooperation And Development Agreement, Commitment Two                                      
Debt Instrument [Line Items]                                      
Cooperative and development activities               $ 1,500,000                      
Period of revenue recognition               19 months                      
Yaskawa | 2020 Cooperation and Development Agreement                                      
Debt Instrument [Line Items]                                      
Cooperative and development activities             $ 4,000,000                        
Proceeds from collaborators           $ 750,000 $ 1,000,000     $ 1,800,000                  
Revenue recognized for collaboration development activities               $ 375,000 334,000                    
Yaskawa                                      
Debt Instrument [Line Items]                                      
Conversion price per share on convertible note payable (in dollars per share) | $ / shares $ 5.00   $ 5.12                                
Number of shares issued (in shares) | shares 3,120,000                                    
Warrant to purchase shares issued, number of shares $ 650,000                                    
Exercise price (in usd per share) | $ / shares $ 6.00                                    
Exercisable period of warrants (in years) 3 years                                    
Tranche B Loan                                      
Debt Instrument [Line Items]                                      
Long-term loan facility                 8,000,000                    
Repayment of Nexperia debt   $ 8,000,000                                  
Tranche B-1 Loan                                      
Debt Instrument [Line Items]                                      
Long-term loan facility                           $ 2,000,000     $ 2,000,000    
Repayment of Nexperia debt   $ 8,000,000                                  
Tranche C Note                                      
Debt Instrument [Line Items]                                      
Long-term loan facility                                   $ 12,000,000  
Interest rate per annum                                   6.00%  
Interest expense accrued               182,000 166,000                    
Yaskawa Note                                      
Debt Instrument [Line Items]                                      
Interest rate per annum                                     1.00%
Unsecured subordinated convertible promissory note         $ 15,600,000                           $ 15,000,000
Maximum number of shares of common stock issuable (in shares) | shares     3,076,171                                
Changes in fair value of promissory note                 (1,000,000)                    
Interest expense                 $ (38,000)                    
Yaskawa Note | Yaskawa                                      
Debt Instrument [Line Items]                                      
Principal and unpaid interest of convertible note $ 15,600,000                                    
Number of shares issued (in shares) | shares         3,120,000                            
Other income               $ 1,200,000                      
Loan and Security Agreement (LSA)                                      
Debt Instrument [Line Items]                                      
Principal amount of development loans outstanding                         $ 8,000,000   $ 10,000,000        
Revolving loan                           $ 12,000,000   $ 10,000,000   $ 10,000,000  
Long-term loan facility                                   $ 15,000,000  
Repayment of Nexperia debt       $ 5,000,000                              
Interest rate per annum                                   6.00%